12-Month Lobbying Summary - Organization

Sandoz Canada Inc. / Michel Robidoux, CEO & General Manager

Registration Summary

Currently active - Last Updated: 2024-10-17 - Projected End Date: 2025-04-30

Who is lobbying?

Sandoz Canada Inc. (Address & business activities)

Michel Robidoux, CEO & General Manager

Government Funding

Did Sandoz Canada Inc. request or receive government funding within the last 12 months? No

Coalition Members Information

Sandoz Canada Inc. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Sandoz Canada Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Novartis Pharma Canada (Address information)

Other Affiliates

The activities of Sandoz Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Sandoz Canada Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discuss matters related to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Health
Improve regulatory environment and utilization rates for generics and biosimilars.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Health
Raising awareness to government officials for generic and biosimilar products development by Sandoz Canada Inc. and the potential savings realized by the healthcare system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Health

Subject matter details in previous versions

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discuss on how to help patients who need medical cannabis to reduce pain, nausea or symptoms related to their illness, to have access to a pharmacist to receive advice on the optimal use of medical cannabis and reduce the risk of drug interactions.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly	Cannabis, Health
Raising awareness to government officials about the challenge of drug supply in the context of Covid-19 and post-Covid-19.	Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly	Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Finance
Health
Member(s) of the BC Legislative Assembly
Office of the Premier
Provincial Health Services Authority

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Guillaume Lefevre
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Raymond Maghirang
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No